Clinical Trials Browser

Phase 4 × Recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all

NCT06876649 2026-03-02

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Phase 4 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell